The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

A study showed notable differences in bone mineral density between children on steroids and those not on steroids, with 84% ...

The treatment procedures are required in the case of the severity of the condition. The patient then needs to go for a kidney ...

Decreased mastication Animal and limited human data have shown that intake limited to liquid or soft foods leads to salivary gland atrophy and subsequent decrease in salivary flow. More studies ...

HRS-5965 is under development for the treatment of complement mediated primary or secondary glomerular diseases, paroxysmal nocturnal hemoglobinuria, glomerulonephritis ... was also under development ...

The Phase 1 GALLOP study evaluating investigational therapy, CB-010, for treatment of lupus nephritis (LN) has officially started ... as lupus that is not characterized by Class III/IV ...

Acute interstitial nephritis and ANCA-associated vasculitis ... For instance, sofosbuvir and ribavirin therapy has led to ANCA-associated glomerulonephritis (8), presumably through the conversion of ...

About IgA Nephropathy (IgAN) IgAN is a serious, progressive, life-threatening, B cell-mediated chronic kidney disease that is the most common cause of primary (idiopathic) glomerulonephritis ...